Kringle Pharma, Inc. (TYO:4884)
Japan
· Delayed Price · Currency is JPY 859.00
-19.00 (-2.16%)
Jun 6, 2025, 3:30 PM JST
Kringle Pharma Revenue
Kringle Pharma had revenue of 16.84M JPY in the quarter ending March 31, 2025, a decrease of -32.64%. This brings the company's revenue in the last twelve months to 72.00M, down -7.69% year-over-year. In the fiscal year ending September 30, 2024, Kringle Pharma had annual revenue of 80.00M with 15.94% growth.
Revenue (ttm)
72.00M
Revenue Growth
-7.69%
P/S Ratio
81.57
Revenue / Employee
4.80M
Employees
15
Market Cap
5.87B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,222.12B |
| Takeda Pharmaceutical Company | 4,581.55B |
| Daiichi Sankyo Company | 1,886.26B |
| HOYA Corporation | 869.37B |
| Terumo | 1,036.17B |
| Otsuka Holdings | 2,393.18B |
| Astellas Pharma | 1,912.32B |
| Olympus | 997.33B |